PD-L2 was shown to be moderately or strongly expressed in most tumor cells, to interact with PD-1 and to dramatically inhibit TCR-mediated proliferation, CD4+ T cell cytokine production and T-cell cytolysis [46]. Here, CD4 is linked to neoplasm.